Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population-Reference-Cited by-同舟云学术

Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population

Published:2021-11-03 Issue:1 Volume:52 Page:81-92
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Kumada Takashi¹^ORCID,Toyoda Hidenori²^ORCID,Yasuda Satoshi²,Ito Takanori³,Tanaka Junko⁴^ORCID

Affiliation:

1. Department of Nursing Faculty of Nursing Gifu Kyoritsu University Ogaki Gifu Japan

2. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Gifu Japan

3. Department of Gastroenterology and Hepatology Nagoya University Graduate School of Medicine Nagoya Japan

4. Department of Epidemiology, Infectious Disease Control, and Prevention Hiroshima University Institute of Biomedical and Health Sciences Hiroshima Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13723

Reference39 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

2. Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

3. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

4. Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years

5. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2024-07-05

2. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?;Current Hepatology Reports;2024-02-12

3. The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis;Frontiers in Cellular and Infection Microbiology;2023-09-12

4. Changing the Epidemiology and Pattern of Hepatitis B and C in the South of Fars Province, Southern Iran: 2015 - 2021;Jundishapur Journal of Chronic Disease Care;2023-08-14

5. What will it take to cure hepatitis B?;Hepatology Communications;2023-03-24